Clinical Trial Update: Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating intravenous magnesium for sickle cell vaso-occlusive crisis has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-09-07